372243072	372243072	CD	B-NP	O
|	|	NNP	I-NP	O
UH	UH	NNP	I-NP	O
|	|	VBD	B-VP	O
64469558	64469558	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
2246012	2246012	CD	B-NP	O
|	|	CC	I-NP	O
8/17/2004	8/17/2004	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Tachyarrhythmia	Tachyarrhythmia	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation/flutter	fibrillation/flutter	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/19/2004	3/19/2004	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/12/2004	11/12/2004	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
FENRICH	FENRICH	NNP	B-NP	O
,	,	,	O	O
RHETT	RHETT	NNP	B-NP	O
858-88-89-5	858-88-89-5	CD	I-NP	O
Arizona	Arizona	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
5/11/04	5/11/04	CD	B-NP	O
AT	AT	NN	I-NP	O
03	03	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NN	I-NP	O
CONTINGENT	CONTINGENT	NN	I-NP	O
UPON	UPON	NN	I-NP	O
HO	HO	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
WILL	WILL	MD	B-VP	O
D/C	D/C	NNP	B-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
STREJCEK	STREJCEK	NN	B-NP	O
,	,	,	O	O
MICHAEL	MICHAEL	NNP	B-NP	O
VAN	VAN	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Skilled	Skille	VBN	B-VP	O
Nursing	Nurse	VBG	B-VP	O
Facility	Facility	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ECASA	ECASA	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
4/13/04	4/13/04	CD	B-NP	O
by	by	IN	B-PP	O
WIDDISON	WIDDISON	NNP	B-NP	O
,	,	,	O	O
WILMER	WILMER	NNP	B-NP	O
OSCAR	OSCAR	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H.	M.P.H.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ECASA	ECASA	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
95830767	95830767	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
POSSIBLE	POSSIBLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
NSAIDs	NSAID	NNS	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
-LRB-	-LRB-	JJ	B-NP	O
naprosyn	naprosyn	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
POSSIBLE	POSSIBLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
NAPROXEN	NAPROXEN	NN	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
Unknown	Unknown	JJ	B-ADJP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
tolerates	tolerate	VBZ	B-VP	O
DILTIAZEM	DILTIAZEM	NN	B-NP	B-protein
30	30	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QID	QID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	O
instructs	instruct	NNS	I-NP	O
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
8/13/04	8/13/04	CD	B-NP	O
by	by	IN	B-PP	O
DERIGGI	DERIGGI	NNP	B-NP	O
,	,	,	O	O
CEDRIC	CEDRIC	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
METOPROLOL	METOPROLOL	NNP	B-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
&	&	CC	I-NP	O
DILTIAZEM	DILTIAZEM	NNP	I-NP	O
HCL	HCL	NN	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
Insufficient	Insufficient	JJ	B-NP	O
rate	rate	NN	I-NP	O
control	control	NN	I-NP	O
on	on	IN	B-PP	O
one	one	CD	B-NP	O
agent	agent	NN	I-NP	O
.	.	.	O	O

LASIX	LASIX	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
4/13/04	4/13/04	CD	B-NP	O
by	by	IN	B-PP	O
ZAMZAM	ZAMZAM	NNP	B-NP	O
,	,	,	O	O
ANTONY	ANTONY	NNP	B-NP	O
BRANDON	BRANDON	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H.	M.P.H.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LASIX	LASIX	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
41167258	41167258	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
POSSIBLE	POSSIBLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	NN	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
rash	rash	NN	B-NP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
tolerates	tolerate	VBZ	B-VP	O
PREDNISONE	PREDNISONE	NN	B-NP	O
10	10	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QAM	QAM	NN	I-NP	O
METFORMIN	METFORMIN	NN	I-NP	O
850	850	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
REMERON	REMERON	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
MIRTAZAPINE	MIRTAZAPINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
7.5	7.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
ARICEPT	ARICEPT	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
DONEPEZIL	DONEPEZIL	NN	I-NP	O
HCL	HCL	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
LEVALBUTEROL	LEVALBUTEROL	NN	I-NP	O
0.63	0.63	CD	B-NP	O
MG	MG	NNP	I-NP	O
INH	INH	NNP	I-NP	O
QID	QID	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
TOPROL	TOPROL	NN	I-NP	O
XL	XL	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
METOPROLOL	METOPROLOL	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
SUST	SUST	NN	I-NP	O
.	.	.	O	O

REL	REL	NN	B-NP	B-protein
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O

100	100	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
8/9	8/9	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/11/04	5/11/04	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NN	B-NP	O
SERIOUS	SERIOUS	NN	I-NP	O
INTERACTION	INTERACTION	NN	I-NP	O
:	:	:	O	O
DILTIAZEM	DILTIAZEM	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
needs	need	NNS	I-NP	O
for	for	IN	B-PP	O
HR	HR	NN	B-NP	B-protein
control	control	NN	I-NP	I-protein
FOLATE	FOLATE	JJ	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
FOLIC	FOLIC	NN	I-NP	I-protein
ACID	ACID	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
1	1	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
VITAMIN	VITAMIN	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
6	6	CD	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
PYRIDOXINE	PYRIDOXINE	NN	I-NP	I-protein
HCL	HCL	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
50	50	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
VITAMIN	VITAMIN	NN	I-NP	I-protein
B12	B12	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
CYANOCOBALAMIN	CYANOCOBALAMIN	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	O
100	100	CD	I-NP	O
MCG	MCG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
1800	1800	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Ambulate	Ambulate	VBP	B-VP	O
w	w	NN	B-NP	O
/	/	SYM	B-NP	O
assistance	assistance	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Olsten	Olsten	NNP	I-NP	O
9/17/04	9/17/04	CD	I-NP	O
at	at	IN	B-PP	O
3	3	CD	B-NP	O
:	:	SYM	O	O
50	50	CD	B-NP	O
p.m.	p.m.	RB	I-NP	O
scheduled	schedule	VBN	I-VP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Steed	Steed	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Cardiology	Cardiology	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1	1	CD	I-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
p.m.	p.m.	RB	I-NP	O
11/10/04	11/10/04	CD	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
ALLERGY	ALLERGY	NNP	B-NP	O
:	:	:	O	O
HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	NNP	B-NP	O
,	,	,	O	O
Penicillins	Penicillins	NNP	B-NP	O
,	,	,	O	O
NSAIDs	NSAIDs	NNP	B-NP	O
,	,	,	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
,	,	,	O	O
NAPROXEN	NAPROXEN	NNP	B-NP	O
,	,	,	O	O
ACE	ACE	NNP	B-NP	O
Inhibitor	Inhibitor	NNP	I-NP	O
,	,	,	O	O
SEAFOOD	SEAFOOD	NNP	B-NP	O
,	,	,	O	O
TOMATOES	TOMATOES	NNP	B-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Chest	Chest	NNP	B-NP	O
Pain	Pain	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Tachyarrhythmia	Tachyarrhythmia	NNP	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation/flutter	fibrillation/flutter	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
NIDDM	NIDDM	NNP	I-NP	O
,	,	,	O	O
Htn	Htn	NNP	B-NP	B-protein
,	,	,	O	O
Asthma	Asthma	NNP	B-NP	O
,	,	,	O	O
h/o	h/o	JJ	B-NP	O
Rheumatic	Rheumatic	JJ	I-NP	O
heart	heart	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
Bipolar	Bipolar	JJ	B-NP	O
disorder	disorder	NN	I-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
Cataract	Cataract	NNP	I-NP	O
surgery	surgery	NN	I-NP	O
,	,	,	O	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
djd	djd	NN	B-NP	O
,	,	,	O	O
Temporal	Temporal	NNP	B-NP	O
Arteritis	Arteritis	NNP	I-NP	O
,	,	,	O	O
CVA	CVA	NNP	B-NP	O
OPERATIONS	OPERATIONS	NNPS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNPS	I-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
None	None	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
Chest	Ch	JJS	B-NP	O
pain	pain	NN	I-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
69y/o	69y/o	CD	B-NP	O
female	female	JJ	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
MMP	MMP	NN	I-NP	B-protein
,	,	,	O	O
including	include	VBG	B-PP	O
CHF	CHF	NN	B-NP	B-protein
-LRB-	-LRB-	SYM	B-NP	O
EF	EF	NN	I-NP	O
=	=	SYM	B-VP	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
10/6/04	10/6/04	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
NIDDM	NIDDM	NN	B-NP	B-protein
,	,	,	O	O
Afib	Afib	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
mult	mult	JJ	B-NP	O
CVAs	CVA	NNS	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
USOH	USOH	NN	I-NP	B-protein
until	until	IN	B-PP	O
8am	8am	CD	B-NP	O
the	the	DT	B-NP	O
DOA	DOA	NN	I-NP	B-protein
,	,	,	O	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
twitches	twitch	NNS	B-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
eyes	eye	NNS	I-NP	O
and	and	CC	I-NP	O
mouth	mouth	NN	I-NP	O
;	;	:	O	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
episode	episode	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
pt	pt	NN	I-NP	O
.	.	.	O	O

was	be	VBD	O	O
A	A	NNP	B-NP	O
&	&	CC	I-NP	O
OX	OX	NNP	I-NP	O
3/no	3/no	CD	I-NP	O
LOC	LOC	NNP	I-NP	O
.	.	.	O	O

Per	Per	NNP	B-NP	O
report	report	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
had	have	VBN	I-VP	O
these	these	DT	B-NP	O
sx	sx	NN	I-NP	O
previously	previously	RB	B-ADVP	O
.	.	.	O	O

VS	VS	NN	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
were	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

At	At	IN	B-PP	O
8	8	CD	B-NP	O
:	:	:	O	O
45	45	CD	B-NP	O
am	am	NN	I-NP	O
per	per	IN	B-PP	O
report	report	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
pt	pt	NN	I-NP	O
began	begin	VBD	B-VP	O
moaning	moan	VBG	I-VP	O
and	and	CC	O	O
complained	complain	VBD	B-VP	O
of	of	IN	B-PP	O
left	left	JJ	B-NP	B-protein
sided	sided	JJ	I-NP	I-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
localized	localize	VBD	B-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
breast	breast	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
skin	skin	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
clammy	clammy	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
pt	pt	NN	I-NP	O
.	.	.	O	O

reports	report	NNS	B-NP	O
no	no	DT	B-NP	O
radiation	radiation	NN	I-NP	O
of	of	IN	B-PP	O
sx	sx	NN	B-NP	O
,	,	,	O	O
SOB	SOB	NN	B-NP	B-protein
,	,	,	O	O
N/V	N/V	NN	B-NP	O
,	,	,	O	O
palpitations	palpitation	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
dizziness	dizziness	NN	B-NP	O
.	.	.	O	O

Proxy	Proxy	NN	B-NP	O
did	do	VBD	B-VP	O
note	note	NN	B-NP	O
that	that	IN	B-SBAR	O
pt	pt	NN	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
``	``	``	I-NP	O
congestive	congestive	JJ	I-NP	O
cough	cough	NN	I-NP	O
''	''	''	O	O
for	for	IN	B-PP	O
past	past	JJ	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

VS	VS	NN	B-NP	O
at	at	IN	B-PP	O
nursing	nurse	VBG	B-VP	O
home	home	NN	B-NP	O
durnig	durnig	NN	I-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
were	be	VBD	B-VP	O
P57-92	P57-92	NN	B-NP	O
,	,	,	O	O
BP	BP	NN	B-NP	B-DNA
104/70	104/70	CD	I-NP	I-DNA
,	,	,	O	O
O2	O2	NN	B-NP	O
98	98	CD	I-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
then	then	RB	B-ADVP	O
brought	bring	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
RMH	RMH	NN	I-NP	O
ED	ED	NN	I-NP	O
,	,	,	O	O
where	where	WRB	B-ADVP	O
she	she	PRP	B-NP	O
no	no	RB	B-ADVP	O
longer	longer	RBR	I-ADVP	O
c/o	c/o	JJ	B-NP	O
sx	sx	NN	I-NP	O
but	but	CC	O	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
tachy	tachy	JJ	B-ADJP	O
in	in	IN	B-PP	O
afib	afib	JJ	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
HR	HR	NN	B-NP	O
120s-130s	120s-130s	CD	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
ED	ED	NNP	B-NP	O
VS	VS	NNP	I-NP	O
:	:	:	O	O
T	T	NN	B-NP	O
99.2	99.2	CD	I-NP	O
;	;	:	O	O
BP	BP	NN	B-NP	O
129/116	129/116	CD	I-NP	O
;	;	:	O	O
RR14	RR14	NN	B-NP	B-protein
;	;	:	O	O
O2	O2	NN	B-NP	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
.	.	.	O	O

PE	PE	NN	B-NP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
cataracts	cataract	NNS	B-NP	O
b/l	b/l	NN	I-NP	O
,	,	,	O	O
CN	CN	NN	B-NP	O
intact	intact	JJ	B-ADJP	O
,	,	,	O	O
lungs	lung	VBZ	B-VP	O
CTA	CTA	NN	B-NP	O
b/l	b/l	NN	I-NP	O
,	,	,	O	O
CVS	CVS	NN	B-NP	O
tachy	tachy	NN	I-NP	O
,	,	,	O	O
?	?	.	O	O

S4	S4	NN	B-NP	B-protein
,	,	,	O	O
abd	abd	NN	B-NP	O
s/nt	s/nt	NN	I-NP	O
,	,	,	O	O
ext	ext	JJ	B-NP	O
www	www	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
.	.	.	O	O

unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
cooperate	cooperate	VB	I-VP	O
for	for	IN	B-PP	O
full	full	JJ	B-NP	O
neurological	neurological	JJ	I-NP	O
exam	exam	NN	I-NP	O
.	.	.	O	O

Labs	Lab	NNS	B-NP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
K	K	NN	B-NP	O
of	of	IN	B-PP	O
5.4	5.4	CD	B-NP	O
,	,	,	O	O
Ca	Ca	NNP	B-NP	O
of	of	IN	B-PP	O
8.1	8.1	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
WCT	WCT	NN	B-NP	O
of	of	IN	B-PP	O
15.02	15.02	CD	B-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	O
:	:	:	O	O
tachy	tachy	NN	B-NP	O
at	at	IN	B-PP	O
111	111	CD	B-NP	O
,	,	,	O	O
reg	reg	NN	B-NP	O
rhythm	rhythm	NN	I-NP	O
?	?	.	O	O

sinus	sinus	NN	B-NP	O
vs.	vs.	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
flutter	flutter	NN	I-NP	O
.	.	.	O	O

.5	.5	CD	B-NP	O
mm	mm	NN	I-NP	O
ST	ST	NN	I-NP	O
depression	depression	NN	I-NP	O
in	in	IN	B-PP	O
V5	V5	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
TW	TW	NNP	I-NP	O
changes	change	NNS	I-NP	O
,	,	,	O	O
QW	QW	NNP	B-NP	O
in	in	IN	B-PP	O
3	3	CD	B-NP	O
,	,	,	O	O
aVF	aVF	NN	B-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
unchanged	unchanged	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

CXR	CXR	NN	B-NP	B-protein
:	:	:	O	O
No	No	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
pulm	pulm	NN	B-NP	O
edema	edema	NN	I-NP	O
/	/	SYM	B-NP	O
infiltrate	infiltrate	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
given	give	VBN	B-PP	O
50	50	CD	B-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
lopressor	lopressor	NN	I-NP	O
and	and	CC	O	O
5mg	5mg	NN	B-NP	O
IV	IV	CD	I-NP	O
lopressor	lopressor	NN	I-NP	O
X	X	SYM	B-NP	O
4	4	CD	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
persistent	persistent	JJ	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
low	low	JJ	I-NP	O
100s	100	NNS	I-NP	O
.	.	.	O	O

ASSESSMENT	ASSESSMENT	NN	B-NP	O
:	:	:	O	O
69	69	CD	B-NP	O
y/o	y/o	NN	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
h/o	h/o	NN	B-NP	B-protein
CHF	CHF	NN	I-NP	I-protein
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
tachyarrhythmias	tachyarrhythmia	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
CVAs	CVA	NNS	B-NP	B-protein
presents	present	VBZ	B-VP	O
w	w	NN	B-NP	O
/	/	SYM	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
facial	facial	JJ	B-NP	O
twitching	twitching	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
admitted	admit	VBN	B-VP	O
for	for	IN	B-PP	O
stabilization	stabilization	NN	B-NP	O
of	of	IN	B-PP	O
HR	HR	NN	B-NP	B-protein
and	and	CC	I-NP	O
r/o	r/o	NN	I-NP	O
MI	MI	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
CARDS	CARDS	NN	I-NP	O
:	:	:	O	O
Ischemia	Ischemia	NN	B-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
ruled	rule	VBD	B-VP	O
out	out	RP	B-PRT	O
by	by	IN	B-PP	O
enzymes/EKG	enzymes/EKG	NN	B-NP	B-protein
X3	X3	NN	I-NP	I-protein
.	.	.	O	O

Did	Do	VBD	B-VP	O
not	not	RB	I-VP	O
complain	complain	VB	I-VP	O
of	of	IN	B-PP	O
CP	CP	NN	B-NP	B-protein
/	/	SYM	B-NP	I-protein
SOB	SOB	NN	I-NP	I-protein
during	during	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
ASA	ASA	NNP	B-NP	O
,	,	,	O	O
Beta	Beta	NNP	B-NP	O
blocker	blocker	NNP	I-NP	O
Pump	Pump	NNP	I-NP	O
:	:	:	O	O
H/o	H/o	NN	B-NP	O
CHF	CHF	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
EF	EF	NN	I-NP	O
50-55	50-55	CD	B-NP	O
%	%	NN	I-NP	O
in	in	IN	B-PP	O
7/19/04	7/19/04	CD	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
by	by	IN	B-PP	O
PE	PE	NN	B-NP	O
,	,	,	O	O
CXR	CXR	NN	B-NP	B-protein
.	.	.	O	O

On	On	IN	B-PP	O
lasix	lasix	CD	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	NN	I-NP	O
qd	qd	NN	I-NP	O
.	.	.	O	O

Repeat	Repeat	NN	B-NP	O
ECHO	ECHO	NN	I-NP	O
11/8/04	11/8/04	CD	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
mild	mild	JJ	I-NP	O
interval	interval	JJ	I-NP	O
reduction	reduction	NN	I-NP	O
in	in	IN	B-PP	O
LV	LV	NN	B-NP	B-protein
EF	EF	NN	I-NP	I-protein
down	down	RB	B-ADVP	O
to	to	TO	B-PP	O
35-40	35-40	CD	B-NP	O
%	%	NN	I-NP	O
without	without	IN	B-PP	O
significant	significant	JJ	B-NP	O
valvular	valvular	JJ	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
.	.	.	O	O

Rhythm	Rhythm	NN	B-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
tachy	tachy	NN	I-NP	O
to	to	TO	B-PP	O
110s	110	NNS	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
but	but	CC	O	O
hemodynamically	hemodynamically	RB	B-ADJP	O
stable	stable	JJ	I-ADJP	O
.	.	.	O	O

O/N	O/N	NN	B-NP	B-protein
HD1	HD1	NN	I-NP	I-protein
had	have	VBD	B-VP	O
episode	episode	NN	B-NP	O
of	of	IN	B-PP	O
afib	afib	NN	B-NP	O
at	at	IN	B-PP	O
130s-140s	130s-140	NNS	B-NP	O
,	,	,	O	O
desat	desat	NN	B-NP	O
to	to	TO	B-PP	O
88	88	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
complaints	complaint	NNS	I-NP	O
of	of	IN	B-PP	O
CP	CP	NN	B-NP	B-DNA
.	.	.	O	O

Given	Give	VBN	B-NP	O
diltiazem	diltiazem	NN	I-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
return	return	NN	I-NP	O
of	of	IN	B-PP	O
HR	HR	NN	B-NP	B-protein
to	to	TO	B-PP	O
low	low	JJ	B-NP	B-protein
100s	100	NNS	I-NP	I-protein
-LRB-	-LRB-	TO	B-PP	I-protein
baseline	baseline	NN	B-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

Started	Start	VBN	B-NP	O
diltiazem	diltiazem	NN	I-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	NN	I-NP	O
QID	QID	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
drop	drop	NN	I-NP	O
in	in	IN	B-PP	O
HR	HR	NN	B-NP	O
to	to	TO	B-PP	O
70s-80s	70s-80	NNS	B-NP	O
,	,	,	O	O
w	w	NN	B-NP	O
/	/	SYM	B-NP	O
irregular	irregular	JJ	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

Per	Per	NNP	B-NP	O
EKG	EKG	NNP	I-NP	O
,	,	,	O	O
?	?	.	O	O

sinus	sinus	NN	B-NP	O
arrhythmia	arrhythmia	NN	I-NP	O
vs	v	NNS	I-NP	O
?	?	.	O	O

atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
normal	normal	JJ	I-NP	O
rate	rate	NN	I-NP	O
.	.	.	O	O

TSH	TSH	NN	B-NP	O
pending	pending	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
HD4	HD4	NN	B-NP	B-protein
,	,	,	O	O
pt	pt	NN	B-NP	O
.	.	.	O	O

had	have	VBD	O	O
episode	episode	NN	B-NP	O
of	of	IN	B-PP	O
bradycardia	bradycardia	NN	B-NP	O
down	down	RB	B-ADVP	O
to	to	TO	B-PP	O
50s	50s	CD	B-NP	O
-LRB-	-LRB-	HYPH	O	O
approximately	approximately	RB	B-NP	O
1	1	CD	I-NP	O
hour	hour	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
asymptomatic	asymptomatic	JJ	B-ADJP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
heart	heart	NN	B-NP	O
block	block	NN	I-NP	O
.	.	.	O	O

Toprol	Toprol	NN	B-NP	B-protein
XL	XL	NN	I-NP	I-protein
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	B-protein
dose	dose	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
100	100	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
qd	qd	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
diltiazem	diltiazem	NN	B-NP	O
was	be	VBD	B-VP	O
kept	keep	VBN	I-VP	O
at	at	IN	B-PP	O
qid	qid	NN	B-NP	O
dosing	dosing	NN	I-NP	O
upon	upon	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
the	the	DT	B-NP	O
brief	brief	JJ	I-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
bradycardia	bradycardia	NN	B-NP	O
and	and	CC	I-NP	O
concerns	concern	NNS	I-NP	O
for	for	IN	B-PP	O
both	both	CC	O	O
bradycardia	bradycardia	NN	B-NP	O
and	and	CC	O	O
heart	heart	NN	B-NP	O
block	block	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
decided	decide	VBN	I-VP	O
to	to	TO	I-VP	O
place	place	VB	I-VP	O
a	a	DT	B-NP	O
continuous	continuous	JJ	I-NP	O
loop	loop	NN	I-NP	O
monitor	monitor	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
in	in	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
cardiology	cardiology	NN	I-NP	O
on	on	IN	B-PP	O
November	November	NNP	B-NP	O
and	and	CC	B-PP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-protein
on	on	IN	B-PP	O
November	November	NNP	B-NP	O
2	2	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
NEURO	NEURO	NNP	I-NP	O
:	:	:	O	O
Has	Has	NNP	B-NP	O
hx	hx	NN	I-NP	O
of	of	IN	B-PP	O
CVA	CVA	NN	B-NP	B-protein
.	.	.	O	O

Head	Head	JJ	B-NP	O
CT	CT	NN	I-NP	O
on	on	IN	B-PP	O
8/17/04	8/17/04	NN	B-NP	O
shows	show	VBZ	B-VP	O
old	old	JJ	B-NP	O
infarct	infarct	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
new	new	JJ	I-NP	O
lesion	lesion	NN	I-NP	O
.	.	.	O	O

Per	Per	NNP	B-NP	O
proxy	proxy	NN	I-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
.	.	.	O	O

back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
baseline	baseline	NN	B-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
upon	upon	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
facial	facial	JJ	B-NP	O
twitching	twitching	NN	I-NP	O
during	during	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
aricept	aricept	NN	B-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
ID	ID	NN	I-NP	O
:	:	:	O	O
WCT	WCT	NN	B-NP	O
15.03	15.03	CD	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
86	86	CD	B-NP	O
%	%	NN	I-NP	O
PMNs	PMN	NNS	I-NP	B-cell_type
.	.	.	O	O

Pt	Pt	NN	B-NP	O
afebrile	afebrile	RB	B-ADVP	O
,	,	,	O	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
.	.	.	O	O

Given	Give	VBN	B-NP	O
hx	hx	NN	I-NP	O
.	.	.	O	O

of	of	IN	B-PP	O
cough	cough	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
sputum	sputum	NN	I-NP	O
gs/cx	gs/cx	NN	I-NP	O
were	be	VBD	B-VP	O
done	do	VBN	I-VP	O
and	and	CC	O	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

WCT	WCT	NN	B-NP	O
down	down	RB	B-ADVP	O
to	to	TO	B-PP	O
8.03	8.03	CD	B-NP	O
by	by	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
.	.	.	O	O

on	on	IN	B-PP	O
prednisone	prednisone	NN	B-NP	O
for	for	IN	B-PP	O
temporal	temporal	JJ	B-NP	O
arteritis	arteritis	NN	I-NP	O
;	;	:	O	O
this	this	DT	B-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
been	be	VBN	I-VP	O
the	the	DT	B-NP	O
cause	cause	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
WCT	WCT	NN	I-NP	O
elevation	elevation	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
unlikely	unlikely	JJ	B-ADJP	O
as	as	IN	B-SBAR	O
WCT	WCT	NN	B-NP	O
dropped	drop	VBN	B-VP	O
by	by	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
ENDO	ENDO	NNP	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
metformin	metformin	NN	B-NP	O
850	850	CD	I-NP	O
mg	mg	NN	I-NP	O
BID	BID	NN	I-NP	O
for	for	IN	B-PP	O
DM	DM	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
had	have	VBD	B-VP	O
pt	pt	NN	B-NP	O
.	.	.	O	O

on	on	IN	B-PP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
insuling	insule	VBG	B-VP	O
during	during	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

5	5	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
FEN	FEN	NNP	I-NP	O
:	:	:	O	O
Potassium	Potassium	NN	B-NP	O
initially	initially	RB	B-ADJP	O
elevated	elevated	JJ	I-ADJP	O
,	,	,	O	O
but	but	CC	O	O
down	down	RB	B-ADVP	O
to	to	TO	B-PP	O
3.8	3.8	CD	B-NP	O
by	by	IN	B-PP	O
discharge	discharge	NN	B-NP	O
;	;	:	O	O
No	No	DT	B-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
.	.	.	O	O

Ca	Ca	NN	B-NP	O
was	be	VBD	B-VP	O
low	low	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
repleted	replete	VBN	I-VP	O
-	-	HYPH	B-PRT	O
it	it	PRP	B-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
been	be	VBN	I-VP	O
responsible	responsible	JJ	B-ADJP	O
for	for	IN	B-PP	O
facial	facial	JJ	B-NP	O
twitches	twitch	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
ADA	ADA	NN	B-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
RHEUM	RHEUM	NNP	I-NP	O
:	:	:	O	O
H/o	H/o	NNP	B-NP	O
temporal	temporal	JJ	I-NP	O
arteritis	arteritis	NN	I-NP	O
.	.	.	O	O

Continued	Continue	VBN	B-NP	O
prednisone	prednisone	NN	I-NP	O
10mg	10mg	CD	I-NP	O
qd	qd	NN	I-NP	O
.	.	.	O	O

ESR	ESR	NN	B-NP	B-protein
rechecked	rechecke	VBD	B-VP	O
on	on	IN	B-PP	O
day	day	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
per	per	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Newberg	Newberg	NNP	I-NP	O
To	To	TO	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
up	up	RP	B-PRT	O
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
CODE	CODE	NN	I-NP	O
:	:	:	O	O
FC	FC	NN	B-NP	O
.	.	.	O	O

*	*	SYM	O	O
Per	Per	NNP	B-NP	O
Health	Health	NNP	I-NP	O
proxy	proxy	NN	I-NP	O
,	,	,	O	O
Jackie	Jackie	NNP	B-NP	O
Bhatia	Bhatia	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
phone	phone	NN	I-NP	O
857-284-3232	857-284-3232	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
's	's	POS	B-NP	O
code	code	NN	I-NP	O
status	status	NN	I-NP	O
had	have	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
FC	FC	NN	B-NP	O
after	after	IN	B-PP	O
being	be	VBG	B-VP	O
years	year	NNS	B-NP	O
of	of	IN	B-PP	O
DNR/DNI	DNR/DNI	NN	B-NP	O
.	.	.	O	O

Code	Code	NN	B-NP	O
status	status	NN	I-NP	O
was	be	VBD	B-VP	O
revisited	revisit	VBN	I-VP	O
this	this	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Ms.	Ms.	NNP	B-NP	O
Points	Points	NNP	I-NP	O
requested	request	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
pt	pt	NN	I-NP	O
.	.	.	O	O

be	be	VB	B-VP	O
full	full	JJ	B-NP	O
code	code	NN	I-NP	O
.	.	.	O	O

Discussed	Discuss	VBN	B-NP	O
issue	issue	NN	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Ollhoff	Ollhoff	NNP	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
will	will	MD	B-VP	O
revisit	revisit	VB	I-VP	O
this	this	DT	B-NP	O
issue	issue	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
and	and	CC	I-NP	O
proxy	proxy	NN	I-NP	O
at	at	IN	B-PP	O
her	her	PRP$	B-NP	O
next	next	JJ	I-NP	O
appt	appt	NN	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
continue	continue	VBP	B-VP	O
to	to	TO	I-VP	O
take	take	VB	I-VP	O
your	your	PRP$	B-NP	O
home	home	NN	I-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
added	add	VBN	I-VP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
medication	medication	NN	I-NP	O
,	,	,	O	O
Diltiazem	Diltiazem	NNP	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
you	you	PRP	B-NP	O
need	need	VBP	B-VP	O
to	to	TO	I-VP	O
take	take	VB	I-VP	O
four	four	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
you	you	PRP	B-NP	O
should	should	MD	B-VP	O
receive	receive	VB	I-VP	O
a	a	DT	B-NP	O
portable	portable	JJ	I-NP	O
heart	heart	NN	I-NP	O
monitor	monitor	NN	I-NP	O
that	that	WDT	B-NP	O
will	will	MD	B-VP	O
record	record	VB	I-VP	O
your	your	PRP$	B-NP	O
heart	heart	NN	I-NP	O
rhythms	rhythm	NNS	I-NP	O
continuously	continuously	RB	B-ADVP	O
for	for	IN	B-PP	O
one	one	CD	B-NP	O
month	month	NN	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
schedule	schedule	VB	I-VP	O
an	an	DT	B-NP	O
appt	appt	NN	I-NP	O
.	.	.	O	O

to	to	TO	B-VP	O
see	see	VB	I-VP	O
Dr.	Dr.	NNP	B-NP	O
Mclaine	Mclaine	NNP	I-NP	O
within	within	IN	B-PP	O
1	1	CD	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
should	should	MD	B-VP	O
see	see	VB	I-VP	O
Dr.	Dr.	NNP	B-NP	O
Waylon	Waylon	NNP	I-NP	O
Back	Back	NNP	I-NP	O
in	in	IN	B-PP	O
cardiology	cardiology	NN	B-NP	O
on	on	IN	B-PP	O
November	November	NNP	B-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
:	:	SYM	O	O
30	30	CD	B-NP	O
p.m.	p.m.	NN	I-NP	O
and	and	CC	O	O
Dr.	Dr.	NNP	B-NP	O
Guariglia	Guariglia	NNP	I-NP	O
on	on	IN	B-PP	O
June	June	NNP	B-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
:	:	SYM	O	O
50	50	CD	B-NP	O
p.m.	p.m.	RB	I-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
you	you	PRP	B-NP	O
have	have	VBP	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
dizziness	dizziness	NN	B-NP	O
,	,	,	O	O
weakness	weakness	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
other	other	JJ	B-NP	O
symptoms	symptom	NNS	I-NP	O
go	go	VBP	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ER	ER	NN	I-NP	B-protein
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
.	.	.	O	O

to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Peloquin	Peloquin	NNP	I-NP	O
on	on	IN	B-PP	O
9/17/04	9/17/04	CD	B-NP	O
at	at	IN	B-PP	O
3	3	CD	B-NP	O
:	:	SYM	O	O
50	50	CD	B-NP	O
p.m.	p.m.	NN	I-NP	O
For	For	IN	B-PP	O
HR	HR	NN	B-NP	O
control	control	NN	I-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
.	.	.	O	O

started	start	VBN	B-VP	O
on	on	IN	B-PP	O
diltiazem	diltiazem	NN	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
QID	QID	NN	I-NP	O
.	.	.	O	O

Will	Will	MD	O	O
likely	likely	RB	B-NP	O
transition	transition	NN	I-NP	O
to	to	TO	B-PP	O
long-acting	long-acting	JJ	B-NP	O
diltiazem	diltiazem	NN	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
scheduled	schedule	VBN	I-VP	O
to	to	TO	I-VP	O
see	see	VB	I-VP	O
Dr.	Dr.	NNP	B-NP	O
Mcgrue	Mcgrue	NNP	I-NP	O
in	in	IN	B-PP	O
cardiology	cardiology	NN	B-NP	O
for	for	IN	B-PP	O
consideration	consideration	NN	B-NP	O
of	of	IN	B-PP	O
amio	amio	NN	B-NP	O
for	for	IN	B-PP	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
sent	send	VBN	I-VP	O
home	home	NN	B-ADVP	O
with	with	IN	B-PP	O
loop	loop	NN	B-NP	O
monitor	monitor	NN	I-NP	O
for	for	IN	B-PP	O
possible	possible	JJ	B-NP	O
bradycardia/heart	bradycardia/heart	NN	I-NP	O
block	block	NN	I-NP	O
on	on	IN	B-PP	O
nodal	nodal	JJ	B-NP	O
agents	agent	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
VALENSUELA	VALENSUELA	NNP	B-NP	O
,	,	,	O	O
JERAMY	JERAMY	NNP	B-NP	O
PASQUALE	PASQUALE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H.	M.P.H.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ED39	ED39	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5/11/04	5/11/04	CD	I-NP	O
@	@	SYM	B-NP	O
02	02	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

